CareDx (CDNA) Competitors $22.70 +1.26 (+5.88%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDNA vs. RDNT, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, CON, and PRVAShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include RadNet (RDNT), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. CareDx vs. RadNet Option Care Health Guardant Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk. Does the media prefer CDNA or RDNT? In the previous week, CareDx had 5 more articles in the media than RadNet. MarketBeat recorded 13 mentions for CareDx and 8 mentions for RadNet. CareDx's average media sentiment score of 0.25 beat RadNet's score of 0.22 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 2 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is CDNA or RDNT more profitable? RadNet has a net margin of -0.25% compared to CareDx's net margin of -45.90%. RadNet's return on equity of 4.29% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% RadNet -0.25%4.29%1.45% Which has better earnings & valuation, CDNA or RDNT? RadNet has higher revenue and earnings than CareDx. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$280.32M4.32-$190.28M-$2.70-8.37RadNet$1.62B2.76$3.04M-$0.07-861.31 Which has more risk & volatility, CDNA or RDNT? CareDx has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500. Do analysts prefer CDNA or RDNT? CareDx presently has a consensus price target of $28.33, indicating a potential upside of 25.41%. RadNet has a consensus price target of $79.75, indicating a potential upside of 32.26%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than CareDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57RadNet 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Does the MarketBeat Community believe in CDNA or RDNT? CareDx received 89 more outperform votes than RadNet when rated by MarketBeat users. However, 66.10% of users gave RadNet an outperform vote while only 65.97% of users gave CareDx an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44065.97% Underperform Votes22734.03% RadNetOutperform Votes35166.10% Underperform Votes18033.90% Do institutionals & insiders believe in CDNA or RDNT? 77.9% of RadNet shares are owned by institutional investors. 4.9% of CareDx shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryRadNet beats CareDx on 12 of the 18 factors compared between the two stocks. Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.21B$3.05B$5.37B$9.10BDividend YieldN/A16.58%5.37%4.00%P/E Ratio-8.3515.5287.4217.48Price / Sales4.32206.461,281.3978.80Price / CashN/A393.5036.6032.90Price / Book4.685.114.934.65Net Income-$190.28M-$33.85M$117.96M$224.76M7 Day Performance2.46%6.79%2.21%2.97%1 Month Performance9.62%2.78%3.20%4.97%1 Year Performance144.25%18.78%26.67%21.85% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx3.8241 of 5 stars$22.70+5.9%$28.33+24.8%+131.8%$1.22B$280.32M-8.41740RDNTRadNet4.1155 of 5 stars$66.07-3.9%$84.75+28.3%+58.4%$4.89B$1.77B-943.728,970OPCHOption Care Health4.7639 of 5 stars$27.60+15.0%$29.71+7.7%-9.0%$4.70B$4.78B23.195,600Positive NewsGHGuardant Health3.4436 of 5 stars$37.59+2.4%$40.60+8.0%+57.9%$4.64B$692.26M-8.871,779Short Interest ↓News CoverageGap UpSHCSotera Health2.786 of 5 stars$12.98-1.0%$16.08+23.9%-13.4%$3.68B$1.12B51.923,000VCYTVeracyte3.9821 of 5 stars$42.52+2.4%$41.13-3.3%+59.0%$3.30B$425.33M-283.47790News CoveragePositive NewsBTSGBrightSpring Health Services2.2402 of 5 stars$17.22+0.3%$18.65+8.3%N/A$3.00B$10.59B-66.2335,000News CoverageGap DownLFSTLifeStance Health Group1.222 of 5 stars$7.69-0.5%$8.70+13.1%+17.2%$2.94B$1.21B-29.589,325Positive NewsSGRYSurgery Partners1.8479 of 5 stars$20.81+0.8%$36.56+75.7%-37.1%$2.65B$2.99B-43.3512,200CONConcentra Group Holdings ParentN/A$20.53+4.1%$28.50+38.8%N/A$2.61B$1.88B0.0011,000Lockup ExpirationPositive NewsPRVAPrivia Health Group2.5042 of 5 stars$21.13+3.0%$24.88+17.8%+6.8%$2.54B$1.72B211.321,102 Related Companies and Tools Related Companies RadNet Alternatives Option Care Health Alternatives Guardant Health Alternatives Sotera Health Alternatives Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDNA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
